Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug;37(8):1705-1711.
doi: 10.1007/s00467-021-05342-y. Epub 2021 Nov 23.

Cystinuria: an update on pathophysiology, genetics, and clinical management

Affiliations
Review

Cystinuria: an update on pathophysiology, genetics, and clinical management

Viola D'Ambrosio et al. Pediatr Nephrol. 2022 Aug.

Abstract

Cystinuria is the most common genetic cause of nephrolithiasis in children. It is considered a heritable aminoaciduria as the genetic defect affects the reabsorption of cystine and three other amino acids (ornithine, lysine, and arginine) in the renal proximal tubule. Patients affected by this condition have elevated excretion of cystine in the urine, and because of this amino acid's low solubility at normal urine pH, patients tend to form cystine calculi. To date, two genes have been identified as disease-causative: SLC3A1 and SLC7A9, encoding for the two subunits of the heterodimeric transporter. The clinical features of this condition are solely related to nephrolithiasis. The diagnosis is usually made during infancy or adolescence, but cases of late diagnosis are common. The goal of therapy is to reduce excretion and increase the solubility of cystine, through both modifications of dietary habits and pharmacological treatment. However, therapeutic interventions are not always sufficient, and patients often have to undergo several surgical procedures during their lives to treat recurrent nephrolithiasis. The goal of this literature review is to synthesize the available evidence on diagnosis and management of patients affected by cystinuria in order to provide physicians with a practical tool that can be used in daily clinical practice. This review also aims to shed some light on new therapy directions with the aim of ameliorating kidney outcomes while improving adherence to treatment and quality of life of cystinuric patients.

Keywords: Chronic kidney disease; Cystinuria; Genetics; Nephrolithiasis.

PubMed Disclaimer

References

    1. Eggermann T, Venghaus A, Zerres K (2012) Cystinuria: an inborn cause of urolithiasis. Orphanet J Rare Dis 7:19. https://doi.org/10.1186/1750-1172-7-19 - DOI - PubMed - PMC
    1. Streeper NM, Wertheim ML, Nakada SY, Penniston KL (2017) Cystine stone formers have impaired health-related quality of life compared with noncystine stone formers: a case-referent study piloting the Wisconsin Stone Quality of Life Questionnaire among patients with cystine stones. J Endourol 31:S48–S53. https://doi.org/10.1089/end.2016.0564 - DOI - PubMed
    1. Barbey F, Joly D, Rieu P et al (2000) Medical treatment of cystinuria: critical reappraisal of long-term results. J Urol 163:1419–1423. https://doi.org/10.1016/s0022-5347(05)67633-1 - DOI - PubMed
    1. Leslie SW, Sajjad H, Nazzal L (2020) Cystinuria. In: StatPearls. StatPearls Publishing, Treasure Island (FL). https://www.ncbi.nlm.nih.gov/books/NBK470527/
    1. Calonge MJ, Gasparini P, Chillarón J et al (1994) Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine. Nat Genet 6:420–425. https://doi.org/10.1038/ng0494-420 - DOI - PubMed

Substances

LinkOut - more resources